|
2024
|
Invention
|
Anti-cd33 antibodies and uses thereof.
Anti-CD33 antibodies are described. The anti-CD33 antibod... |
|
|
Invention
|
Siglec-8 antibodies and uses thereof.
Siglec-8 antibodies and uses thereof are described. The Si... |
|
|
Invention
|
Systems and methods for mobile-enabled targeted nanopore sequencing with mobile-enabled real-time... |
|
|
Invention
|
Treating alphaherpesvirus infections using gene drive technology. Provided are genetically modifi... |
|
|
Invention
|
Modulation of fusobacterium nucleatum subspecies animalis clade 2 microbes. Compositions and meth... |
|
|
Invention
|
De novo designed alpha (v) beta (8) integrin selective minibinder. Alpha(v) beta (8) integrin (αv... |
|
|
Invention
|
Personalized insights into tumor evolution and ai-based treatment decision support systems and me... |
|
|
Invention
|
Methods for identifying and using inhibitors of casein kinase 1 epsilon isoform for inhibiting th... |
|
|
Invention
|
Epigenomic analysis of formalin-fixed paraffin-embedded samples. in situ in situin situ methods f... |
|
|
Invention
|
Optimized drug screening using artificial intelligence. In some aspects, the present disclosure p... |
|
|
Invention
|
Treatment of hsv-2 using a meganuclease.
Described herein are compositions and methods for reduc... |
|
|
Invention
|
Treatment of hsv-2 using a meganuclease. Described herein are compositions and methods for reduci... |
|
|
Invention
|
Pro-inflammatory cytokine enhanced steap1 recombinant receptors. Genetic constructs expressing a ... |
|
|
Invention
|
Targeting gpatch8 for treating sf3b1-mutant cancers. Embodiments of the present disclosure provid... |
|
|
Invention
|
Methods of treating swi/snf deregulated cancers.
The present disclosure provides therapeutic tre... |
|
|
P/S
|
Association services for promoting the public interest and awareness in cancer research and educa... |
|
|
P/S
|
Reagents and monoclonal antibodies for in vitro scientific or research use.
Diagnostic reagents a... |
|
|
P/S
|
Reagents and monoclonal antibodies for in vitro scientific
or research use. Diagnostic reagents ... |
|
|
Invention
|
Cross-flavivirus binding domains and uses thereof. Binding domains that bind the four dengue viru... |
|
|
Invention
|
Compositions and methods for accurately identifying mutations.
The present disclosure provides c... |
|
|
Invention
|
Targeting prac1 in steroid hormone driven cancer. In some embodiments, the present disclosure pro... |
|
|
Invention
|
Methods of treating pancreatic cancer.
Provided herein are biomarkers, methods of diagnosing, me... |
|
|
Invention
|
Compositions and methods for treatment, diagnosis, and prognosis of leukemia based on leukemia-sp... |
|
|
Invention
|
Anti-pd-1 chimeric antigen receptor t cells and therapeutic uses thereof. The present technology ... |
|
|
Invention
|
Anti-ror1 antibodies and uses thereof.
The present disclosure relates to anti-ROR1 binding prote... |
|
|
Invention
|
Method and compositions for cellular immunotherapy.
The present invention provides nucleic acids... |
|
|
Invention
|
Fgfr inhibitor methods of treatment, screening, and testing. unc-23unc-23) sequence that is assoc... |
|
|
Invention
|
Binding proteins specific for mutant p53 and uses thereof. The present disclosure provides compos... |
|
|
Invention
|
Viral particle producer cells with landing pad-integrated viral vectors. Systems and methods to m... |
|
|
Invention
|
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarrier.
C... |
|
|
Invention
|
Single-domain antibodies that bind ror1. Single-domain antibodies that bind receptor tyrosine kin... |
|
|
Invention
|
Methods of eliciting antibodies that bind to full-length glycosylated hiv-1 env using multimerize... |
|
2023
|
P/S
|
Apparel, namely, t-shirts, polo shirts, tank tops, long
sleeve shirts; athletic apparel, namely,... |
|
|
P/S
|
Apparel, namely, t-shits, polo shirts, tank tops, long sleeve shirts; athletic apparel, namely, s... |
|
|
P/S
|
Apparel, namely, t-shits, polo shirts, tank tops, long
sleeve shirts; athletic apparel, namely, ... |
|
|
Invention
|
Method for treating neurological diseases through glial pruning regulation. Methods for regulatin... |
|
|
Invention
|
Methods and compositions to enhance humoral immunity to reduce cytomegalovirus infection and reac... |
|
|
Invention
|
Combination therapies for treatment of bcma-related cancers and autoimmune disorders.
The presen... |
|
|
Invention
|
Antibodies that bind the tumor (t) antigen of merkel cell polyomavirus and related diagnostics.
... |
|
|
Invention
|
Anti-folate receptor conjugate therapy for cancer treatment.
Methods and compositions for provid... |
|
|
P/S
|
Downloadable electronic publications in the nature of newsletters, pamphlets, brochures, magazine... |
|
|
Invention
|
Tcrs specific for minor histocompatibility (h) antigen ha-1 and uses thereof.
The present disclo... |
|
|
P/S
|
Apparel, namely, t-shirts, polo shirts, tank tops, long sleeve shirts; athletic apparel, namely, ... |
|
|
Invention
|
Immunomodulatory fusion proteins and uses thereof.
The present disclosure relates to immunomodul... |
|
2022
|
Invention
|
Treatments for cancers utilizing cell-targeted therapies and associated research protocols.
Targ... |
|
|
Invention
|
T cell immunotherapy for hematologic malignancies having an sf3b1 mutation.
Provided are composi... |
|
|
P/S
|
Reagents and monoclonal antibodies for in vitro scientific or research use Downloadable electroni... |
|
|
P/S
|
Reagents and monoclonal antibodies for in vitro scientific or research use Diagnostic reagents an... |
|
|
Invention
|
Cd-90 targeted lipid nanoparticles.
The present invention relates to compositions and methods fo... |
|
|
Invention
|
Mesothelin-specific t cell receptors and methods of using same.
Mesothelin-specific binding prot... |
|
|
Invention
|
Molecular signatures of long-term covid-19 and treatment thereof.
In various embodiments, provid... |
|
|
Invention
|
Protective antibodies against respiratory viral infections.
Antibodies that protect against resp... |
|
|
Invention
|
Treatment for hsv-1 using a meganuclease.
Embodiments of the present disclosure are directed to ... |
|
2021
|
Invention
|
Neutralizing monoclonal antibodies against covid-19.
The present application relates to neutrali... |
|
|
Invention
|
Compositions and methods for cellular immunotherapy.
The present application concerns chimeric c... |
|
|
Invention
|
Pd-l1 binding peptides and peptide complexes and methods of use thereof.
Described herein are cy... |
|
|
Invention
|
Immunotherapy targeting sox2 antigens.
The present disclosure provides compositions and methods ... |
|
2014
|
P/S
|
Printed publications, namely, newsletters, pamphlets, brochures, magazines, instruction sheets an... |
|
2012
|
P/S
|
Promoting public awareness about cancer and cancer research Charitable fund raising Organization ... |
